Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Morning Bell 30 July

Jessica Amir
July 30, 2020

Morning Bell 29 July

Jessica Amir
July 29, 2020

How to use ETFs in your portfolio

Bell Direct
July 28, 2020

Morning Bell 28 July

Jessica Amir
July 28, 2020

Morning Bell 27 July

Jessica Amir
July 27, 2020

Weekly Wrap 24 July

Jessica Amir
July 24, 2020

Morning Bell 24 July

Paulina Peters
July 24, 2020

Morning Bell 23 July

Jessica Amir
July 23, 2020

Morning Bell 22 July

Jessica Amir
July 22, 2020

Morning Bell 21 July

Jessica Amir
July 21, 2020

Morning Bell 20 July

Jessica Amir
July 20, 2020